Skip to content
Recall Observatory FDA recall evidence

Drug product

Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-274-01

D-0220-2026

November 13, 2025

Class II

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 97990
Status
Ongoing
Classification
Class II
Quantity
32736 vials
Official record key
drug-enforcement:D-0220-2026

Official wording

Reason: Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.

Code information: Lot #: WB00006, Exp 12/31/2026

Distribution pattern: FL, MA, MI & OH

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification